AB Science
AB Science has announced the granting of a patent in Japan for the use of Masitinib in the treatment of progressive forms of multiple sclerosis (MS) until 2041. This is the first country to grant a patent for MS.

Argan

The real estate company specializing in logistics platforms will report its annual results.

Ateme
The video broadcasting specialist will release its fourth-quarter revenue. 
Getlink
The operator of the Channel Tunnel will report its fourth-quarter revenue.

GTT
GTT announced that it received, during the fourth quarter of 2025, an order from HD Korea Shipbuilding & Offshore Engineering (HD KSOE) for the design of tanks for three new LNG carriers.

Interparfums
The perfume creator will unveil its fourth-quarter revenue.

Ipsen
The French pharmaceutical company has won its case before the International Chamber of Commerce (ICC), ending a major dispute with Galderma and thus securing its R&D portfolio.

Michelin
Preliminary financial figures for Bibendum for 2025 show a free cash flow before acquisitions of €2.1 billion, a level above the range (between €1.5 and €1.8 billion) indicated on October 13, 2025.

Pierre et Vacances
The tourism and leisure group will report its first-quarter revenue.

Stef
The provider of temperature-controlled transport and logistics services dedicated to food products will present its fourth-quarter revenue.  

Stif
The explosion protection specialist will report its fourth-quarter revenue.

Sword Group
The company specializing in technological and digital transformation will report its fourth-quarter revenue.

Thales
The space subsidiary of Thales and Leonardo has reached a crucial milestone in space intelligence with the awarding of a strategic contract for the development of a national sovereign radar imaging capability.

Ubisoft
Ubisoft has announced a major overhaul of its organization, operational model, and portfolio in order to regain creative leadership, enhance agility, and return to sustainable growth, while aiming for stronger cash generation.